small molecule kinase inhibitors

Kinnate Biopharma upsizes IPO and prices above range at $20 a share
Marketwatch
Fri, 12/4/20 - 10:53 am
Kinnate Biopharma
IPOs
NASDAQ
small molecule kinase inhibitors